The 4th Annual Medical Device Biocompatibility Conference, taking place on the 26th – 27th November 2026 in Berlin, Germany, will bring together high-level experts, industry leaders, and regulatory professionals to explore the evolving landscape of biological safety in medical devices. As the field shifts from traditional compliance toward more dynamic, risk-based strategies, this conference provides a vital platform for knowledge exchange, innovation, and collaboration.
Across two intensive days, participants will gain insights into the latest developments in biocompatibility evaluation, regulatory expectations, and scientific advancements shaping the industry. Key discussions will address the implementation challenges and opportunities within ISO 10993-1, including the anticipated 2025 updates, as well as alignment complexities between global regulatory frameworks such as FDA guidance and international standards.
The program will cover the full lifecycle of biological risk assessment—from early concept and material selection through to post-market surveillance—emphasizing practical strategies for integrating toxicological risk assessments, improving clinical relevance of testing, and navigating global harmonization challenges. Special focus will also be placed on reducing animal testing through New Approach Methodologies (NAMs) and leveraging emerging technologies such as artificial intelligence and digital twins for toxicity prediction.
In addition, the conference will explore cutting-edge topics including the biocompatibility of advanced, smart, and nano-engineered biomaterials, biodegradable and bioresorbable devices, and the unique challenges posed by combination products. Long-term implant safety, chronic exposure risks, and effective lifecycle management strategies will also be key areas of discussion.
Looking ahead, the event will highlight the future of biocompatibility—driven by digital innovation, personalization, and smarter evaluation frameworks—equipping attendees with the knowledge and tools needed to stay at the forefront of this rapidly evolving field.
Do not miss this opportunity to connect with senior decision-makers and gain a clear perspective on the transformative impact of rapidly evolving technologies in industry.
We look forward to welcoming you and your colleagues to Berlin, Germany on the 26th – 27th November 2026.
“4th Annual Medical Device Biocompatibility Conference”
will take place as planned on the 26th – 27th November 2026 in Berlin, Germany at one of our Official Hotel Partner.
Venue: Hotel will be announced one month prior the event!
